VF
AST

Virtu Financial’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Virtu Financial’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-44,642
Closed -$58K – 2261
2018
Q3 		$58K Buy
+44,642
New +$69.3K ﹤0.01% 1282
2018
Q2 		– Sell
-34,383
Closed -$50K – 2861
2018
Q1 		$50K Sell
34,383
-37,205
-52% -$77.7K ﹤0.01% 1720
2017
Q4 		$161K Buy
71,588
+56,888
+387% +$144K 0.01% 1765
2017
Q3 		$50K Buy
+14,700
New +$49.5K ﹤0.01% 2231

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's AST Position: Q4 2018 in Review

Virtu Financial sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q4 2018, closing a stake of 44,642 shares — an estimated $58K sold.

Virtu Financial first reported a position in AST in Q3 2017 and held it in 4 quarters. The position peaked at $161K in Q4 2017. 46 funds tracked by Wall St. Rank hold AST as of Q4 2018.

  • Virtu Financial reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q4 2018 after selling out during the quarter.
  • Virtu Financial sold 44,642 Asterias Biotherapeutics Inc. Series A shares in Q4 2018, an estimated $58K.
  • Virtu Financial first reported a position in Asterias Biotherapeutics Inc. Series A in Q3 2017 and held it in 4 quarters.
  • Virtu Financial's Asterias Biotherapeutics Inc. Series A position peaked at $161K in Q4 2017.
  • 46 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q4 2018.

Based on Virtu Financial's 13F filing for Q4 2018, filed 16 Jan 2019.